New Impact Factor for Translational Andrology and Urology: 1.9

Published: 2024-06-21

We are pleased to announce that the Translational Andrology and Urology (TAU) has attained its latest impact factor update for the 2023 citation year: 1.9.

Translational Andrology and Urology (Print ISSN 2223-4683; Online ISSN 2223-4691; Transl Androl Urol; TAU) is an open access, peer-reviewed, monthly journal (quarterly published from Mar. 2012 to Dec. 2014; bimonthly published from Jan. 2015 to Dec. 2020). TAU delivers up-to-date findings and provides current and practical information on basic and clinical research of andrology and urology. It publishes articles that cover various aspects in diseases of male and female urinary tract including kidneys, ureters, bladder, and urethra, and the male reproductive organs like penis, testes, scrotum, prostate, etc. Contributions pertinent to urology and andrology are also included from related fields such as public health, basic sciences, education, sociology, and nursing. TAU has been indexed by PubMed/PubMed Central, Scopus, and Science Citation Index Expanded (SCIE). TAU is endorsed by the Genitourinary Medical Association of China International Exchange and Promotive Association for Medical and Health Care (GUA-CPAM).

We strive to follow the best practices in publishing. The announcement of the journal’s latest impact factor is not only a significant achievement for the journal but also the recognition of its more significant scientific reach. Here, we would like to extend our heartfelt gratitude to all our Editorial Team Members, Guest Editors, authors, and reviewers for their significant contributions.

We look forward to the continuous cooperation with all the individuals mentioned above and those who are interested in related fields to bring more exciting content to readers in the coming future.

Editorial Office
Translational Andrology and Urology

June 21, 2024